These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 27815022)
61. Sigma 1 receptor regulates ERK activation and promotes survival of optic nerve head astrocytes. Zhao J; Mysona BA; Wang J; Gonsalvez GB; Smith SB; Bollinger KE PLoS One; 2017; 12(9):e0184421. PubMed ID: 28898265 [TBL] [Abstract][Full Text] [Related]
62. Ganglioside GM1 Contributes to the State of Insulin Resistance in Senescent Human Arterial Endothelial Cells. Sasaki N; Itakura Y; Toyoda M J Biol Chem; 2015 Oct; 290(42):25475-86. PubMed ID: 26338710 [TBL] [Abstract][Full Text] [Related]
64. Absence of ganglioside GM1 in astroglial cells from newborn rat brain. Asou H; Brunngraber EG Neurochem Int; 1984; 6(1):81-9. PubMed ID: 20488024 [TBL] [Abstract][Full Text] [Related]
65. Phospholipids can influence the interconversion of flat epithelial-like and stellate process-bearing astroglial cells in culture: relationships between molecular structure and biological activity. Skaper SD; Favaron M; Facci L; Leon A Brain Res Dev Brain Res; 1989 Feb; 45(2):265-74. PubMed ID: 2713984 [TBL] [Abstract][Full Text] [Related]
66. Interaction of sialosyl cholesterol with the cell surface of rat astrocytes and its biological activities. Ito J; Kato T; Tanaka R Neurochem Int; 1992 Jun; 20(4):493-9. PubMed ID: 1304865 [TBL] [Abstract][Full Text] [Related]
67. α/β-Peptides as Nanomolar Triggers of Lipid Raft-Mediated Endocytosis through GM1 Ganglioside Recognition. Hetényi A; Szabó E; Imre N; Bhaumik KN; Tököli A; Füzesi T; Hollandi R; Horvath P; Czibula Á; Monostori É; Deli MA; Martinek TA Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335956 [TBL] [Abstract][Full Text] [Related]
68. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease. Ryskamp D; Wu J; Geva M; Kusko R; Grossman I; Hayden M; Bezprozvanny I Neurobiol Dis; 2017 Jan; 97(Pt A):46-59. PubMed ID: 27818324 [TBL] [Abstract][Full Text] [Related]
69. Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. Watanabe S; Ilieva H; Tamada H; Nomura H; Komine O; Endo F; Jin S; Mancias P; Kiyama H; Yamanaka K EMBO Mol Med; 2016 Dec; 8(12):1421-1437. PubMed ID: 27821430 [TBL] [Abstract][Full Text] [Related]
70. Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases. Munguia-Galaviz FJ; Miranda-Diaz AG; Cardenas-Sosa MA; Echavarria R Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768323 [TBL] [Abstract][Full Text] [Related]
71. Sigmar1's Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology. Aishwarya R; Abdullah CS; Morshed M; Remex NS; Bhuiyan MS Front Physiol; 2021; 12():705575. PubMed ID: 34305655 [TBL] [Abstract][Full Text] [Related]
72. Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease. Guo YL; Duan WJ; Lu DH; Ma XH; Li XX; Li Z; Bi W; Kurihara H; Liu HZ; Li YF; He RR Acta Pharmacol Sin; 2021 Apr; 42(4):518-528. PubMed ID: 32724177 [TBL] [Abstract][Full Text] [Related]
73. The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson's Disease (PD) and Major Depressive Disorder (MDD). Yang K; Wang C; Sun T Front Pharmacol; 2019; 10():528. PubMed ID: 31178723 [TBL] [Abstract][Full Text] [Related]
75. Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases. Weng TY; Tsai SA; Su TP J Biomed Sci; 2017 Sep; 24(1):74. PubMed ID: 28917260 [TBL] [Abstract][Full Text] [Related]
76. The σ1 receptor regulates accumulation of GM1 ganglioside-enriched autophagosomes in astrocytes. Kasahara R; Yamamoto N; Suzuki K; Sobue K Neuroscience; 2017 Jan; 340():176-187. PubMed ID: 27815022 [TBL] [Abstract][Full Text] [Related]
77. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes. Reuss B; Unsicker K Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180 [TBL] [Abstract][Full Text] [Related]
78. Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover. Vital MA; Flório JC; Frussa-Filho R; De Lucia R; Tufik S; Palermo-Neto J Life Sci; 1998; 62(13):1161-9. PubMed ID: 9519797 [TBL] [Abstract][Full Text] [Related]
79. A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptors. Ishiwata K; Oda K; Sakata M; Kimura Y; Kawamura K; Oda K; Sasaki T; Naganawa M; Chihara K; Okubo Y; Ishii K Ann Nucl Med; 2006 Oct; 20(8):569-73. PubMed ID: 17134027 [TBL] [Abstract][Full Text] [Related]